National Policy for Rare Diseases 2021 Released

The Union Health Ministry recently released the policy.

Rare Diseases: WHO defines a rare disease as a lifelong disease or disorder that often highly weakens an individual. It has a prevalence of 1 or less per 1000 population.

Example: Haemophilia, Thalassemia, Sickle cell anaemia, and auto-immune diseases among others.
However, every country has its own definition of rare diseases.
The US defines rare diseases as a disease or condition that affects fewer than 200,000 patients in the country.
Likewise, the EU defines rare diseases as life-threatening or chronically debilitating (weakening) conditions. It should affect no more than 5 in 10,000 people.

About National Policy For Rare Diseases,2021:

Aim: The policy aims to lower the incidence and prevalence of rare diseases based on an integrated and comprehensive preventive strategy.
The strategy includes awareness generation, counselling programmes, and providing affordable Health Care among others.

Key Features of the National Policy For Rare Diseases, 2021:

Categorisation: The policy categorizes rare diseases into three groups:
- Group 1: Disorders amenable to one-time curative treatment;
- Group 2: Diseases requiring long-term or lifelong treatment; and
- Group 3: Diseases for which definitive treatment is available, but challenges are to make an optimal patient selection for benefit.
Government Support:
- The government will provide Financial support of up to Rs. 20 lakh under the Umbrella Scheme of Rashtriya Arogya Nidhi for the treatment of those rare diseases listed under Group 1.
- Moreover, Beneficiaries of such financial assistance would not be limited to BPL families.
  - About 40% of the population, eligible under Pradhan Mantri Jan Arogya Yojana, will also be eligible for assistance.
- For group 2, the State Governments can consider supporting specific patients.
  - It includes a rare disease that can be managed with special diets or hormonal supplements or other relatively low-cost interventions (Diseases listed under Group 2).
Voluntary Crowdfunding: The government has said that it will assist in voluntary crowd-funding for the treatment of Group 3. It is because it will be difficult to fully finance the treatment of high-cost rare diseases in Group 3.

Rashtriya Arogya Nidhi scheme:

It provides financial assistance to patients living below the poverty line and who are suffering from major life-threatening diseases, to receive medical treatment.

Source: TH

Join Our Telegram

US Resumes Nuclear Weapon Testing

Formation Day

03 Dec, 25
SHARE

On 1st November, eight Indian states—Andhra Pradesh, Chhattisgarh, Haryana, Karnataka, Kerala, Madhya Pradesh, Punjab, and Tamil Nadu—along with five Union Territories—Andaman and Nicobar Islands, Chandigarh, Delhi, Lakshadweep, and Puducherry—celebrate their Formation Day. This date marks an important milestone in India

Turtle (Kachhua) Wildlife Sanctuary

02 Dec, 25
SHARE

The Turtle Wildlife Sanctuary, also known as the Kachhua Sanctuary, is located in the Varanasi district of Uttar Pradesh. It is recognised as India’s first freshwater turtle wildlife sanctuary, established to conserve endangered turtle species and support the ecological health of the Ganga River. Location and Extent The sanctuary co

Introduction of AI and Computational Thinking (CT) in

02 Dec, 25
SHARE

The Ministry of Education plans to introduce Artificial Intelligence (AI) and Computational Thinking (CT) from Class 3 onwards in the 2026–27 academic year. This initiative is part of the National Curriculum Framework for School Education (NCF-SE) 2023 and aligns with the National Education Policy (NEP) 2020. The aim is to prepare student

Sal Tree

02 Dec, 25
SHARE

Scientists from the Environment Department of Himachal Pradesh University (HPU) in Shimla have recently revealed that the Sal tree (Shorea robusta) is the most effective natural air purifier for combating rising pollution levels. Their findings highlight the tree’s superior capacity to trap dust, absorb gases, and cleanse the air compared

US Resumes Nuclear Weapon Testing

02 Dec, 25
SHARE

The President of the United States has ordered the resumption of nuclear weapon testing after a gap of 33 years, the last test being in 1992. This decision marks a significant shift in global nuclear policy and has far-reaching implications for geopolitics, the environment, and international security. Status of Global Nuclear Weapon Testing